Evaluating the effect of Kori-tofu intake on Hemoglobin A1c values:randomized parallel-group comparative study
Not Applicable
- Conditions
- Persons having HbA1c of 5.8~6.5%, except for persons receiving anti-diabetic treatment
- Registration Number
- JPRN-UMIN000030738
- Lead Sponsor
- Shinshu University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. HbA1c of <5.8% or >6.5% at the time of registration 2. persons under treatment of diabetes 3. patients having chronic kidney disease requiring dietary protein restriction 4. persons having a past history of abnormalities by eating kori-tofu 5. persons having soybean allergy 6. Woman during pregnancy or feeding 7. Accompanying serious diseases 8. Persons who were considered as inappropriate for the participants
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in HbA1c after 12-week Kori-tofu intake
- Secondary Outcome Measures
Name Time Method Changes in body weight, serum levels of glucose, insulin, liver enzymes, HDL-cholesterol, LDL-cholesterol, and triglycerides after 12-week Kori-tofu intake